Ship, cargo insurers reluctant to cover Red Sea transit until ...
Many insurance companies are still reluctant to provide cover for ships and cargoes transiting the Red Sea unless the ground level threat comes down
www.spglobal.comHere’s what I can share about the latest publicly reported information on Suez Canal Insurance (SCI) as of now.
Key updates
- AM Best updated SCI’s outlook in 2025, moving from negative to stable, while affirming SCI’s financial strength rating at B- (Fair) and the long-term issuer credit rating at bb- (Fair). The outlook revision reflected improved operating performance and reduced loss ratios in recent years. This is a positive signal for SCI’s balance sheet resilience, though asset quality remains a concern due to concentration in Egypt.[1]
- Earlier in 2023, AM Best had revised SCI’s outlook to negative from stable, citing macroeconomic and asset risks in Egypt and ongoing underwriting losses then, which contributed to a more cautious assessment of balance sheet strength. The ratings still indicated a strong balance sheet by AM Best’s metrics, but with heightened sensitivity to domestic conditions.[2]
- In 2024, AM Best reaffirmed SCI’s ratings with a negative outlook reported in some sources, while continued to acknowledge the company’s strong risk-adjusted capitalisation but highlighted higher expense ratios and limited business diversification as ongoing considerations. The negative outlook at that time suggested continued risk from Egypt’s operating environment and expense pressures.[9]
Context and background
- Suez Canal Insurance operates primarily in Egypt and is viewed as a mid-tier player within the Egyptian non-life market. Its business mix is concentrated in motor and accident lines, with underwriting results historically weighed down by high expense ratios. The ratings and outlooks are sensitive to Egypt’s macroeconomic conditions and regulatory environment, as well as the company’s ERM maturity and diversification efforts.[1][2][9]
- The insurer has made efforts to formalize its ERM function and improve risk management practices, which market observers view positively in terms of governance and risk awareness, though asset quality remains a consideration given concentration in the region.[1]
What this means for stakeholders
- For policyholders and reinsurers: SCI’s ratings suggest the company remains credible but carries country-specific risk related to Egypt’s economic conditions. Any material deterioration in Egypt could impact SCI’s balance sheet more than a diversified, globally traded peer.[2][1]
- For investors and creditors: A stable outlook with affirmed ratings in 2025 indicates a steadier long-term risk profile than the earlier negative period, though the business remains sensitive to Egypt-specific macro risk and operating expenses. Ongoing improvements in ERM and profitability will be key to sustaining or upgrading ratings.[2][1]
Illustrative note
- If you’re evaluating SCI for potential business or investment decisions, consider tracking: (1) Egypt’s macroeconomic trajectory and inflation/FX stability, (2) SCI’s underwriting performance and expense control trends, (3) progress in ERM enhancements, and (4) any diversification or expansion plans beyond the Egyptian market.[9][1][2]
Would you like a concise 1-page briefing with the latest rating details, or a comparison table showing SCI against peers in Egypt’s non-life market? I can also pull the most recent official AM Best statements and summarize exact rating numbers if you’d like. Note: I’ll provide citations after each factual point.